# J.G.Chemicals share price today (J.G.Chemicals Ltd, NSE: JGCHEM)

> J.G.Chemicals share price today: ₹580.05 at the NSE close on 3 November 2026, up 35.3% in a year. J.G.Chemicals (NSE: JGCHEM) is worth ₹2,275 crore, trades at a P/E of 30.2 and has closed between ₹309.05 and ₹651.30 over the past 52 weeks. > J.G.Chemicals Ltd's share price has risen faster than its earnings: +35.3% in a year, against +2.8% for earnings per share. JGCHEM · Chemicals - Inorganic · data as of 3 November 2026. Page: https://www.sectoralpha.in/stocks/jgchemicals-ltd

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Mixed, from fewer quarters than usual
- Price: ₹580.05 (+35.3% in a year)
- P/E: 30.2× (higher than 80% of the last 2.6 years)
- Revenue (Jun 2026): ₹316 Cr (+45.0% on a year ago)
- Profit (Jun 2026): ₹26.0 Cr (+62.5% on a year ago)
- Operating margin: 11.0% (+2.0 points on a year ago)
- ROCE: 18%, FY26
- Profit that came in as cash: 65%, last 3 years

The main question: the share price moved +35.3% in a year while yearly earnings per share moved +2.8%. The difference came from the market paying a higher multiple. ## What is the J.G.Chemicals share price today? J.G.Chemicals Ltd's share price was ₹580.05 at the close on 3 November 2026. It has been rising for 23 weeks. That is 16.4% above its average price over the last 200 trading days. In the last 52 weeks it traded between ₹309 and ₹651, and at that close it sat 79% of the way up from that low. Over the past 13 weeks it has done better than the NIFTY 500, and it has stayed ahead for 19 weeks in a row. Over the last 2.6 years the share price moved +198% while the NIFTY 500 moved +12%, so it is ahead of the index over that whole period. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What changed at J.G.Chemicals this quarter? Three changes stood out: revenue up on a year earlier for 9 quarters in a row, indian funds and insurers (DIIs) cut their stake for 3 quarters in a row and highest quarterly profit in 14 quarters. 1. Revenue up on a year earlier for 9 quarters in a row In the June 2026 quarter revenue was ₹316 crore, +45% on a year earlier. Why: Revenue rose because demand was strong across tyres, rubber, ceramics, pharma and specialty chemicals, and the company sold more in every category. Next results: check whether that demand carries into this quarter, as management said it was continuing. From the earnings call on 10 Aug 2026. 2. Indian funds and insurers (DIIs) cut their stake for 3 quarters in a row From 3.5% to 2.1% of the company by the September 2026 quarter. 3. Highest quarterly profit in 14 quarters Profit of ₹26 crore in the June 2026 quarter is the highest of the last 14 quarters. Why: Profit was the highest because the company ran its plants fuller, sold more higher-priced special orders, cut costs and sold more non-tyre products. Inventory timing also helped a little. Next results: check whether higher-value orders and cost cuts keep the profit margin up as the inventory timing help fades. From the earnings call on 10 Aug 2026. ## What are J.G.Chemicals' latest quarterly results? For April to June 2026 (the quarter ended 30 June 2026), J.G.Chemicals reported revenue of ₹316 crore, up 45.0% from ₹218 crore a year earlier, and a profit of ₹26.0 crore, up 62.5% from ₹16.0 crore. ### J.G.Chemicals results: April to June 2026 against a year earlier

| Measure | April to June 2026 | April to June 2025 | Change |
| --- | --- | --- | --- |
| Revenue | ₹316 crore | ₹218 crore | +45.0% |
| Profit | ₹26.0 crore | ₹16.0 crore | +62.5% |
| Earnings per share | ₹6.40 | ₹4.02 | +59.2% |
| Operating margin | 11.0% | 9.0% | +2.0 points |

The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). J.G.Chemicals' management discussed these results on a call held on 10 August 2026; what it said is further down this page. (From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.)

## What is the J.G.Chemicals share price history? J.G.Chemicals closed at ₹580.05 on 3 November 2026, up 35.3% from ₹428.65 a year earlier (31 October 2025). Its highest weekly close since March 2024 was ₹651.30 on 28 August 2026. ### J.G.Chemicals share price: then and now

| When | Close | Change to 3 Nov 2026 |
| --- | --- | --- |
| 1 week ago · 23 Oct 2026 | ₹574.30 | +1.0% |
| 1 month ago · 1 Oct 2026 | ₹610.30 | −5.0% |
| 6 months ago · 30 Apr 2026 | ₹404.20 | +43.5% |
| 1 year ago · 31 Oct 2025 | ₹428.65 | +35.3% |
| Earliest weekly close in our records · 15 Mar 2024 | ₹194.75 | +197.8% |
| Highest weekly close since March 2024, also the 52-week high · 28 Aug 2026 | ₹651.30 | −10.9% |
| Lowest weekly close since March 2024 · 28 Mar 2024 | ₹172.25 | +236.7% |
| 52-week low (weekly close) · 23 Jan 2026 | ₹309.05 | +87.7% |

Weekly closing prices. Each change is the move from that price to the 3 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes. (143 weekly closes from 15 March 2024 to 3 November 2026.)

## What is the latest news on J.G.Chemicals? 3 Nov 2026: J.G.Chemicals closed at ₹580.05, up 1.0% on the week and down 5.0% on the month. 23 Sep 2026: ex-date for a dividend of ₹1.10 a share. ### Earlier

- 10 Aug 2026: J.G.Chemicals held its results call for April to June 2026. Management guided: Dahej Phase 1 and Naidupeta brownfield commissioning in October to December 2026; Dahej timing narrowed to November. - Results for April to June 2026: Revenue up 45.0% and profit up 62.5% on a year earlier. ## What dividend does J.G.Chemicals pay? J.G.Chemicals paid ₹1.10 a share in regular dividends in the 12 months to 4 November 2026 (1 payment), a yield of 0.19% at the ₹580.05 close on 3 November 2026. The last was a dividend of ₹1.10 a share, ex-date 23 September 2026. ### J.G.Chemicals dividends since 1 April 2021

| Ex-date | Dividend per share | Type |
| --- | --- | --- |
| 23 Sep 2026 | ₹1.10 | Dividend |
| 5 Aug 2025 | ₹1 | Dividend |

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. The record date is the same day as the ex-date for every payment here. 1 of 5 Of the last 5 financial years, years with an NSE dividend record

Not in its latest year. J.G.Chemicals Ltd paid out 0% of its profit as dividends in FY26. It did pay a dividend in 1 of its last 7 reported years, so there is a history but no current dividend. (From the NSE corporate-actions record, read 4 November 2026.)

## What did J.G.Chemicals management say on the latest results call? On the call for April to June 2026, held on 10 August 2026, J.G.Chemicals' management guided: Dahej Phase 1 and Naidupeta brownfield commissioning in October to December 2026; Dahej timing narrowed to November. > “So, we are neutral to zinc prices if you ask me honestly. So whether zinc is at 3,000 or 3,500 or 3,600 it really doesn't matter to us.”
> Anuj Jhunjhunwala, CFO, on the call for April to June 2026

### What management guided

- Dahej Phase 1 capacity 15,000-17,000 MTPA, revenue potential ₹300-400 crore and operating margin 11-12%. - Dahej addition above 40,000 MTPA and combined zinc-chemicals capacity above 115,000 MTPA after both phases; about ₹100 crore of spending and ₹900 crore revenue potential. - Dahej utilization 50-60% in FY28 and 70-80% in FY29; Phase 2 construction to begin as utilization rises. - Current-year operating margin expected to remain in the stated 10-12% range; subsequent consolidated goal approximately 14-15%. Management’s own plans and goals, from our notes of the call. A plan is not a result. Source: [the call transcript](https://files.tijorifinance.com/insight/india/52660/Conference Call/CC-Aug26.pdf). (From the call for April to June 2026, 10 August 2026.)

## What to watch in J.G.Chemicals' next results? When J.G.Chemicals reports July to September 2026, these are the 4 checks that show whether the story is still on course. First: Dahej and Naidupeta commissioning against the indicated window; check equipment installation, approvals and customer readiness. - What to check (from the call)
- Dahej and Naidupeta commissioning against the indicated window; check equipment installation, approvals and customer readiness. - Consolidated operating margin to keep its current profile; check whether higher-value orders and cost initiatives offset inventory timing. - Non-rubber share to keep rising as Gujarat access develops; check ceramic, pharma and specialty-chemical customer additions. - JG-PUR to progress from pilot response toward commercial-scale operations; check capital spending, capacity and revenue-plan disclosure. ## Which stock lists is J.G.Chemicals on? J.G.Chemicals is on one of our India lists: Momentum stocks. [Momentum stocks Market cap cr: 2228.1013513513512](https://www.sectoralpha.in/momentum-stocks-india)

## Is J.G.Chemicals profitable? J.G.Chemicals Ltd earned ₹26.0 Cr of net profit in the Jun 2026 quarter, +62.5% on the same quarter a year earlier. That is the 2nd quarter in a row of profit growth. Full-year FY26 profit was ₹69.0 Cr. Over 6 years profit has grown 30.5% a year on average. That is 8.2% of the quarter's revenue. The same quarter a year earlier earned ₹16.0 Cr. For the full year, FY26 profit was ₹69.0 Cr (+3.0% on the year before). Why profit moved: revenue changed +45.0% on a year earlier and the margin moved +2.0 percentage points. Most of the change came from keeping more of each sale. On average over the last four quarters, profit changed +17.4% and revenue +23.8%. Profit is growing slower than sales: rising costs are taking part of the growth. ## How much revenue does J.G.Chemicals make, and is it growing? J.G.Chemicals Ltd reported ₹316 Cr of revenue in the Jun 2026 quarter, +45.0% on the same quarter a year earlier. That is the 9th quarter in a row with growth on the year before. Over 6 years it has grown 16.0% a year on average. The last full year, FY26, came in at ₹972 Cr. The last four reported quarters add to ₹1,070 Cr. FY26 revenue was ₹972 Cr, +14.8% on the year before. Recent pace: the last four quarters grew +23.8% on average, against 16.0% a year over the longer run, so this year is growing faster than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +24.0%, against +23.8% a year over the last 8 quarters (stabilising); profit over the last 12 months grew +16.4%, against +31.7% a year (rolling over). ## How much of every ₹100 of sales does J.G.Chemicals keep? J.G.Chemicals Ltd's operating margin was 11.0% in the Jun 2026 quarter, 2.0 percentage points higher than the same quarter a year ago. Across 7 years it has been between 4.9% and 10.0%. The latest quarter is above every full year in that period. Why the margin moved: operating margin changed +1.5 percentage points on the year while gross margin changed +0.9 points. So the gain came mostly from the gross margin, which means input costs and prices charged. ## Is J.G.Chemicals' profit turning into cash? Over the last 3 years, 65% of J.G.Chemicals Ltd's reported profit came in as cash from its operations, so most of the profit is real cash. In FY26 it brought in ₹44.0 Cr of operating cash against ₹69.0 Cr of profit. After ₹40.0 Cr of spending on assets, ₹4.0 Cr was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why 65% of profit came in as cash: the cash cycle got 18 days shorter between FY21 and FY26, so cash that used to wait in the business now arrives sooner. When less than 70% of profit comes in as cash, it is the thing to watch on this page. What to look at next: the bigger use of cash is spending on new assets, at 3.6× depreciation over three years. The next section checks what that spending is building. ## Where does J.G.Chemicals' cash go? J.G.Chemicals Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 101 days in FY26, down from 119 days in FY21. It spent ₹54.0 Cr on assets over the last 3 years. Customers take 64 days to pay, and stock sits for 42 days on average. At FY26 sales of ₹972 Cr, each day of that cycle ties up about ₹2.7 Cr, so roughly ₹269 Cr is tied up in the business at any time. FY26: customers took 64 days to pay and stock sat for 42 days, about 1.4 months of sales sitting as stock, for a full cycle of 101 days, shorter than FY21's 119. The full loop: cash goes out to suppliers and production on day 0. Stock sits for 42 days. Customers pay about 64 days after that. Suppliers are paid at 5 days. Together that makes the 101-day cycle. Spending on assets: ₹54.0 Cr over the last 3 years, against ₹15.0 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹8.0 Cr (FY26): assets paid for that are not earning yet. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is J.G.Chemicals' P/E ratio, and how does it compare with its own history? J.G.Chemicals Ltd's P/E is 30.2×, near the high end of its own history: higher than 80% of past readings. Its usual P/E (the middle reading) is 24.9×, over 2.6 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year earnings per share moved +2.8% while the price moved +35.3%. The price did better than earnings, which pushed the multiple up within its own range. In short: the multiple is high against its own past, so the earnings trend underneath matters more than the multiple. A quarterly PEG curve, which only the second data source has, is not shown on this page: its two data sources disagree by up to 11% on reported income across 14 comparable periods. When two sources disagree on a figure, we leave it out on purpose. The gap is a choice, not missing data. ## Is the J.G.Chemicals business getting better or worse? J.G.Chemicals Ltd's business is giving mixed signals. There is no clear direction across the growth lines, with ROCE falling at 18.0%; each line tells part of the story. This is based on 10 quarters of 3 measures, with some gaps. Why it matters: when the lines disagree, each line above matters more than any single label. One or more growth lines have an extreme jump caused by comparing with a near-zero or loss-making quarter. Those jumps are capped before reading and drawn at the edge of the chart, so one odd quarter does not decide the result. The return figures here are yearly, not quarterly. They show level and direction only; they can support the growth lines but never decide the reading alone. This reading has some gaps: at least one line is short, or the return line is not the quarterly series, so treat it with a little more caution. ## How much does J.G.Chemicals earn on its capital? J.G.Chemicals Ltd earned a ROCE of 18% in FY26. That is up from a low of 14% in FY24. We cannot compare its return on capital used with its cost of capital from the data we have. It comes from a 7.1% net margin and 1.71× asset turnover (sales divided by assets). Why the return is what it is (FY26): a 7.1% net margin × 1.71× asset turnover × 1.08× leverage (assets divided by equity) ≈ 13.1% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed. The quarterly return lines and the return-on-capital-used (ROIC) line, which only the second data source has, are not shown on this page: its two data sources disagree by up to 11% on reported income across 14 comparable periods. When two sources disagree on a figure, we leave it out on purpose. The gap is a choice, not missing data. ## Does J.G.Chemicals have too much debt? J.G.Chemicals Ltd had ₹6.0 Cr of borrowings against ₹528 Cr of equity in FY26, so its debt is 0.01× its equity. Its operating profit is 82 times its interest bill. Over 5 years borrowings went from ₹74.0 Cr to ₹6.0 Cr. Over the last 3 of those years it spent ₹54.0 Cr on assets. The spending on assets is being paid for from cash, not new debt. The total-debt and debt-to-equity series, which only the second data source has, are not shown on this page: its two data sources disagree by up to 11% on reported income across 14 comparable periods. When two sources disagree on a figure, we leave it out on purpose. The gap is a choice, not missing data. ## What is the J.G.Chemicals shareholding pattern? Foreign institutions cut their stake in J.G.Chemicals Ltd by 2.8 percentage points over 8 quarters, the biggest change among its owners. Foreign institutions now own 3.8% of the company. Domestic institutions moved −1.6 points over the same period, to 2.1%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings. Over the last two years: Foreign institutions: −2.8 points over 8 quarters, to 3.8%; Domestic institutions: −1.6 points over 8 quarters, to 2.1%; Promoters: +0.0 points over 8 quarters, to 71.0%. Why the owners changed: foreign institutions drove it (−2.8 points), together with domestic institutions (−1.6 points). They reduced their stake. ## How far is J.G.Chemicals from balance-sheet trouble? For J.G.Chemicals Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date. ## How does J.G.Chemicals rank in its industry? 56.9 out of 100, rank 5 of 9 in Chemicals - Inorganic, with 63% of the evidence available. J.G.Chemicals Ltd scores 56.9 out of 100 against the 9 companies it is compared with in Chemicals - Inorganic, ranking 5. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 21.9 + 15.5 + 7.5 + 12 = 56.9. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is J.G.Chemicals compared with? J.G.Chemicals ranks 5 of 9 Chemicals - Inorganic companies on the 4-Factor Sector Score, with 56.9 out of 100. 1. [Deepak Nitrite Ltd](https://www.sectoralpha.in/stocks/deepak-nitrite-ltd) DEEPAKNTR · quiet · Most evidence points up · 100% evidence 70.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 32.7/35 · Revenue 23.8% · Profit 100% · Operating margin change 9 points · 100% evidence Capital efficiency 12.4/25 · ROCE 11.4% · Operating margin 20% · 100% evidence Valuation 15.6/20 · P/E 19.4× · PEG 0.89 · 100% evidence Relative strength 9.3/20 · Lead over its industry -6.1% · Lead over NIFTY 500 -1.7% · 1 year -12.1% · 100% evidence · 0 of 12 weeks ahead Exact sum: 32.7 + 12.4 + 15.6 + 9.3 = 70 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 2. [Indo Borax & Chemicals Ltd](https://www.sectoralpha.in/stocks/indo-borax-chemicals-ltd) INDOBORAX · leader · Evidence leans up · 96% evidence 59.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 24.8/35 · Revenue 28.9% · Profit 47.4% · Operating margin change 5 points · 88% evidence Capital efficiency 18.6/25 · ROCE 15.4% · Operating margin 28% · 100% evidence Valuation 4.4/20 · P/E 25.5× · PEG 1.77 · 100% evidence Relative strength 11.8/20 · Lead over its industry 19.3% · Lead over NIFTY 500 22.2% · 1 year 44% · 100% evidence · 11 of 12 weeks ahead Exact sum: 24.8 + 18.6 + 4.4 + 11.8 = 59.6 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 3. [Ganesh Benzoplast Ltd](https://www.sectoralpha.in/stocks/ganesh-benzoplast-ltd) GANESHBE · losing its lead · Evidence leans up · 74% evidence 57.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.1/35 · Revenue 13.1% · Profit 87.2% · Operating margin change -7 points · 88% evidence Capital efficiency 11.2/25 · ROCE 14.5% · Operating margin 23% · 100% evidence Valuation 16.1/20 · P/E 9.7× · PEG 0.25 · 65% evidence Relative strength 8.7/20 · Lead over its industry n/a · Lead over NIFTY 500 -3.7% · 1 year 1.9% · 25% evidence · 9 of 12 weeks ahead Exact sum: 21.1 + 11.2 + 16.1 + 8.7 = 57.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. [Tanfac Industries Ltd](https://www.sectoralpha.in/stocks/tanfac-industries-ltd) TANFACIND · leader · Evidence leans up · 76% evidence 57.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 12.0/35 · Revenue 13.2% · Profit -29.2% · Operating margin change -1 points · 83% evidence Capital efficiency 16.5/25 · ROCE 23.9% · Operating margin 15% · 95% evidence Valuation 8.5/20 · P/E 112× · PEG n/a · 15% evidence Relative strength 20.0/20 · Lead over its industry 44.2% · Lead over NIFTY 500 48.6% · 1 year 82.1% · 100% evidence · 12 of 12 weeks ahead Exact sum: 12 + 16.5 + 8.5 + 20 = 57 · What this means: Relative strength against the index is 48.6%, and revenue and profit growth are weak. 5. J.G.Chemicals Ltd this page JGCHEM · leader · Evidence leans up · 63% evidence 56.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.9/35 · Revenue 24% · Profit 16.4% · Operating margin change 2 points · 83% evidence Capital efficiency 15.5/25 · ROCE 17.7% · Operating margin 11% · 76% evidence Valuation 7.5/20 · P/E 29.3× · PEG n/a · 50% evidence Relative strength 12.0/20 · Lead over its industry n/a · Lead over NIFTY 500 33.3% · 1 year 31.2% · 25% evidence · 12 of 12 weeks ahead Exact sum: 21.9 + 15.5 + 7.5 + 12 = 56.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. [Sree Rayalaseema Hi-Strength Hypo Ltd](https://www.sectoralpha.in/stocks/sree-rayalaseema-hi-strength-hypo-ltd) SRHHYPOLTD · breaking out · Evidence leans up · 81% evidence 52.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 15.5/35 · Revenue 7.6% · Profit 1.1% · Operating margin change -1 points · 88% evidence Capital efficiency 12.9/25 · ROCE 13.7% · Operating margin 14% · 100% evidence Valuation 12.9/20 · P/E 8.4× · PEG 1.29 · 100% evidence Relative strength 10.7/20 · Lead over its industry n/a · Lead over NIFTY 500 2.9% · 1 year -12.1% · 25% evidence · 8 of 12 weeks ahead Exact sum: 15.5 + 12.9 + 12.9 + 10.7 = 52 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. [POCL Enterprises Ltd](https://www.sectoralpha.in/stocks/pocl-enterprises-ltd) POEL · Evidence leans down · 69% evidence 46.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 7.8/43.75 · Revenue 4.6% · Profit -2% · Operating margin change -3 points · 88% evidence Capital efficiency 19.8/31.25 · ROCE 26.6% · Operating margin 2.5% · 100% evidence Valuation 18.4/25 · P/E 12.2× · PEG 0.71 · 65% evidence Relative strength: no reading this week · its 20 points are shared across the other three Exact sum: 7.8 + 19.8 + 18.4 = 46 (no relative-strength reading this week; its 20 points are shared across the other three) · What this means: There is no relative-strength reading for this week, so the score is built from earnings, capital efficiency and valuation alone. 8. [Archean Chemical Industries Ltd](https://www.sectoralpha.in/stocks/archean-chemical-industries-ltd) ACI · quiet · Most evidence points down · 90% evidence 29.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 6.9/35 · Revenue 6% · Profit -43.3% · Operating margin change -3 points · 100% evidence Capital efficiency 9.6/25 · ROCE 7.4% · Operating margin 24% · 100% evidence Valuation 8.5/20 · P/E 54.7× · PEG n/a · 50% evidence Relative strength 4.8/20 · Lead over its industry -18.3% · Lead over NIFTY 500 -14% · 1 year -33.1% · 100% evidence · 0 of 12 weeks ahead Exact sum: 6.9 + 9.6 + 8.5 + 4.8 = 29.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [Fischer Medical Ventures Ltd](https://www.sectoralpha.in/stocks/fischer-medical-ventures-ltd) FISCHER · quiet · Most evidence points down · 71% evidence 26.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 14.2/35 · Revenue 39.1% · Profit -80% · Operating margin change -269.5 points · 65% evidence Capital efficiency 1.8/25 · ROCE -1.6% · Operating margin -261.1% · 100% evidence Valuation 8.9/20 · P/E 58.4× · PEG n/a · 15% evidence Relative strength 1.7/20 · Lead over its industry -36.8% · Lead over NIFTY 500 -33.5% · 1 year -79% · 100% evidence · 2 of 12 weeks ahead Exact sum: 14.2 + 1.8 + 8.9 + 1.7 = 26.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Chemicals - Inorganic](https://www.sectoralpha.in/sectors/chemicals-inorganic), all 9 compared on one page. ## Which companies are close to J.G.Chemicals in size? J.G.Chemicals is the 4th largest of 9 Chemicals - Inorganic companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: Deepak Nitrite, Tanfac Industries and Archean Chemical Industries. Just below it: Fischer Medical Ventures, Indo Borax & Chemicals and Sree Rayalaseema Hi-Strength Hypo. ### Chemicals - Inorganic companies close in size

1. [Deepak Nitrite Ltd](https://www.sectoralpha.in/stocks/deepak-nitrite-ltd) ₹20,724 crore
2. [Tanfac Industries Ltd](https://www.sectoralpha.in/stocks/tanfac-industries-ltd) ₹7,571 crore
3. [Archean Chemical Industries Ltd](https://www.sectoralpha.in/stocks/archean-chemical-industries-ltd) ₹5,460 crore
4. J.G.Chemicals Ltd ₹2,204 crore
5. [Fischer Medical Ventures Ltd](https://www.sectoralpha.in/stocks/fischer-medical-ventures-ltd) ₹1,732 crore
6. [Indo Borax & Chemicals Ltd](https://www.sectoralpha.in/stocks/indo-borax-chemicals-ltd) ₹1,248 crore
7. [Sree Rayalaseema Hi-Strength Hypo Ltd](https://www.sectoralpha.in/stocks/sree-rayalaseema-hi-strength-hypo-ltd) ₹833 crore

[All 9 Chemicals - Inorganic companies, largest first](https://www.sectoralpha.in/sectors/chemicals-inorganic#all-companies)

### Companies close in size in other industries

1. [NIIT Learning Systems Ltd](https://www.sectoralpha.in/stocks/niit-learning-systems-ltd) ₹2,208 crore · Computer Education
2. [Medi Assist Healthcare Services Ltd](https://www.sectoralpha.in/stocks/medi-assist-healthcare-services-ltd) ₹2,205 crore · Insurance - Proxy
3. J.G.Chemicals Ltd ₹2,204 crore
4. [ESAF Small Finance Bank Ltd](https://www.sectoralpha.in/stocks/esaf-small-finance-bank-ltd) ₹2,192 crore · Banks - Small Finance
5. [Talbros Automotive Components Ltd](https://www.sectoralpha.in/stocks/talbros-automotive-components-ltd) ₹2,181 crore · Auto Ancillaries - Axle shafts

## What else do people ask about J.G.Chemicals? ### What is J.G.Chemicals's share price today? J.G.Chemicals Ltd's share price is ₹580.05, +35.3% over the past year. The whole company is worth ₹2,275 Cr on the market. In the last 52 weeks it traded between ₹309 to ₹651; today it is 79% of the way up from the low, 16.4% above its 200-day average (as of 3 November 2026). ### What were J.G.Chemicals's latest quarterly results? J.G.Chemicals Ltd reported revenue of ₹316 Cr and net profit of ₹26.0 Cr for the Jun 2026 quarter. Revenue rose 45.0% and profit rose 62.5% compared with a year earlier. Earnings per share were ₹6.40. The operating margin was 11.0%, 2.0 percentage points higher than a year earlier (as of 3 November 2026). ### What is J.G.Chemicals's market cap? J.G.Chemicals Ltd's market capitalisation is ₹2,275 Cr at a share price of ₹580.05. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is J.G.Chemicals performing? J.G.Chemicals Ltd's share price has been rising for 23 weeks. In its latest quarter, revenue rose 45.0% and profit rose 62.5% compared with a year earlier. Over the past 13 weeks it has done better than the NIFTY 500, for 19 weeks running (as of 3 November 2026). ### Will J.G.Chemicals's share price go up? This page does not forecast J.G.Chemicals Ltd's share price. What it shows instead: the share price is ₹580.05, and it has been rising for 23 weeks. Its P/E of 30.2× is higher than 80% of its own last 3 years (as of 3 November 2026). ### Who owns J.G.Chemicals? Promoters own 71.0% of J.G.Chemicals Ltd, foreign institutions 3.8%, domestic institutions 2.1% and the public 23.1% (latest quarter). The biggest change over the last two years: Foreign institutions cut their stake by 2.8 percentage points over 8 quarters (as of 3 November 2026). ### Where is J.G.Chemicals in its business cycle? J.G.Chemicals Ltd's FY26 operating margin was 8.0%, against a 7-year range of 4.9% to 10.0%: the middle of its own range, neither a peak nor a low. The latest quarter was 11.0%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the J.G.Chemicals story? The main question: the share price moved +35.3% in a year while yearly earnings per share moved +2.8%. The difference came from the market paying a higher multiple. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is J.G.Chemicals a stock worth studying right now? What the numbers show: J.G.Chemicals Ltd's share price has risen faster than its earnings: +35.3% in a year, against +2.8% for earnings per share. The main open question: whether earnings grow into a price that has already moved. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). ### Is there a J.G.Chemicals share price forecast for 2026? What management itself guided: Dahej Phase 1 and Naidupeta brownfield commissioning in October to December 2026; Dahej timing narrowed to November. ## Lists

- Momentum stocks: https://www.sectoralpha.in/momentum-stocks-india

This is research, not advice. We’re not SEBI-registered.